Showing results (531-540 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Clinical and economic considerations of antiobesity treatment: a review of orlistatArmineh ZohrabianClinicoeconomics and Outcomes Research : CEOR|September 22, 2011
The significance of presenteeism for the value of lost production: the case of rheumatoid arthritisRikke Søgaard, Jan Sørensen, Louise Linde, et al.Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophreniaXiaomei Peng, Haya Ascher-Svanum, Douglas Faries, et al.Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary diseaseSevket Ozkaya, Serhat Findik, Atilla Guven AticiClinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia AGiorgio L Colombo, Sergio Di Matteo, Maria Elisa Mancuso, et al.Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
The economic burden of TNFα inhibitors and other biologic treatments in NorwayJan Norum, Wenche Koldingsnes, Torfinn Aanes, et al.Clinicoeconomics and Outcomes Research : CEOR|November 3, 2011
The role of galenic innovation in improving treatment compliance and persistence: three case studiesYork Zoellner, Maria-Magdalena Balp, Andrea Gili MarcoClinicoeconomics and Outcomes Research : CEOR|November 3, 2011
Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: a Markov model simulationDavid Budd, Leah C Burns, Zhenchao Guo, et al.Clinicoeconomics and Outcomes Research : CEOR|December 14, 2011
Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in IranHamid Reza Rasekh, Ali Imani, Mehran Karimi, et al.Clinicoeconomics and Outcomes Research : CEOR|June 20, 2019
Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritisAlexander Marshall, Kiran Gupta, Michael Pazirandeh, et al.Pageof 102